1. Dennis J,Slamon 美国 University of California Los Angeles 2019拉斯克奖 Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients wit..
2. Sandy,Feng 美国 University of California-San Francisco 2023美国医学院院士 Liver transplantation immunology: Immunosuppression, rejection, and immunomodulation
3. Gillison, Maura L. 美国 The University of Texas MD Anderson Cancer Center 2016美国医学院院士 Noninvasive genomic profiling of somatic mutations in oral cavity cancers
4. 赫捷 中国 中国医学科学院 中国科学院院士 Clinical characteristics, surgical treatments, prognosis, and prognostic factors of primary tracheal..
5. 魏于全 中国 四川大学 中国科学院院士 Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials
6. 樊嘉 中国 复旦大学上海医学院 中国科学院院士 The progress of immune checkpoint therapy in primary liver cancer
7. 赫捷 中国 中国医学科学院 中国科学院院士 Treatment patterns, clinical outcomes, and healthcare resource use associated with advanced/metastat..
8. 于金明 中国 山东第一医科大学 中国工程院院士 Prognostic value of lymphocyte-to-monocyte ratio and systemic immune-inflammation index in non-small..
9. 马骏 中国 中山大学 2023中国科学院院士 Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-ana..
10. Jeanne,Tie 澳大利亚 Peter MacCallum Cancer Center Pharmacogenetics testing (DPYD and UGT1A1) for fluoropyrimidine and irinotecan in routine clinical c..
11. Motohashi, Hozumi 日本 Tohoku University Clinical, Genomic, and Transcriptomic Featurses of Lung Adenocarcinoma With Uncommon EGFR Mut..
12. Ashish M,Kamat 美国 University of Texas MD Anderson Cancer Center Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Soc..
13. Jason A,Efstathiou 美国 Harvard University Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Soc..
14. Seth P,Lerner 美国 Baylor College of Medicine Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Soc..
15. McConkey, David J. 美国 Johns Hopkins University Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Soc..
16. Powles, Thomas 英国 Queen Mary University of London Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Soc..
17. Neal D,Shore 美国 Carolinas Medical Center Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Soc..
18. Richard,Sylvester 比利时 EORTC Headquarters Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Soc..
19. J. Alfred,Witjes 荷兰 Radboud University Nijmegen Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Soc..
20. Matthew D,Galsky 美国 Tisch Cancer Institute Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Soc..